Final Risk Evaluation for Asbestos, Part 1: Chrysotile Asbestos
As part of EPA’s mission to protect human health and the environment, the agency has completed a final risk evaluation for asbestos, part 1: chrysotile asbestos under the Toxic Substances Control Act (TSCA). In the final part 1 risk evaluation, EPA reviewed 32 conditions of use for chrysotile asbestos, the only form of asbestos known to be imported, processed, or distributed for use in the United States, including in manufacturing, processing, distribution in commerce, occupational and consumer uses, and disposal.
Part 1 of the risk evaluation for asbestos contains the agency’s final determinations on which conditions of use present unreasonable risks to human health or the environment based on a robust review of the scientific data. To prepare part 1 of the final risk evaluation, EPA reviewed extensive scientific literature, conducted modeling and other risk assessment activities, and collected toxicity, exposure, and hazard information from many sources.
In March 2024, EPA finalized a rule to protect people from the unreasonable risk identified in part 1 of the risk evaluation for asbestos. Learn more about the risk management rule.
On this page:
- Risk Evaluation Part 1 Findings
- Next Steps and Public participation
- Final risk evaluation and supporting documents
On other pages:
- Read about the steps in EPA’s risk evaluation process for asbestos.
- Learn more about EPA’s risk evaluation process.
- Learn about risk management for asbestos, part 1: chrysotile asbestos.
Risk Evaluation Part 1 Findings
In the December 2020 final risk evaluation for asbestos, part 1: chrysotile asbestos, EPA reviewed the exposures and hazards of chrysotile asbestos uses and made the following final risk findings. Part 1 of the final risk evaluation includes input from the public and peer reviewers as required by TSCA and associated regulations. In making these unreasonable risk determinations, EPA considered the hazards and exposure, magnitude of risk, exposed population, severity of the hazard, uncertainties, and other factors.
EPA found no unreasonable risks to the environment from any conditions of use. For all the conditions of use included in part 1 of the final risk evaluation, EPA found no unreasonable risks to the environment under any of the conditions of use.
EPA found unreasonable risks to human health for uses of chrysotile asbestos.
- Consumers and Bystanders: EPA found unreasonable risks to consumers and bystanders from all consumer uses of chrysotile asbestos. Most consumer products containing chrysotile asbestos have been discontinued. Consumer products still available and for which EPA found unreasonable risk include aftermarket automotive brakes/linings and certain gaskets. Risks to consumers can come from the inhalation of chrysotile asbestos.
- Workers and Occupational Non-Users: Commercial chrysotile asbestos uses for which EPA found unreasonable risk to workers include chlor-alkali diaphragms, sheet gaskets, brake blocks, aftermarket automotive brakes/linings, other vehicle friction products, and other gaskets. Additionally, EPA found unreasonable risks to workers nearby but not in direct contact with chrysotile asbestos (known as occupational non-users) for the use of chlor-alkali diaphragms, sheet gaskets, brake blocks, and other gaskets. Risks to workers and occupational non-users can come from the inhalation of chrysotile asbestos.
Next Steps and Public Participation
In March 2024, EPA finalized a risk management rule for chrysotile asbestos. The rule prohibits ongoing uses of the only known form of asbestos currently imported into the U.S., and will protect people from lung cancer, mesothelioma, ovarian cancer, laryngeal cancer and other health problems caused by asbestos exposure. Learn more about the final rule.
Pursuing Part 2 of the Risk Evaluation for Asbestos. As a result of the November 2019 decision of the U.S. Court of Appeals for the Ninth Circuit in Safer Chemicals Healthy Families v. EPA, the Agency is also evaluating legacy asbestos uses and associated disposals of asbestos in a supplemental effort that is the focus of Part 2 of the Risk Evaluation for Asbestos. Legacy uses and associated disposals of asbestos are conditions of use for which manufacture (including import), processing and distribution in commerce no longer occur, but where use and disposal are still known, intended, or reasonably foreseen to occur (e.g., asbestos in older buildings). EPA will soon release the draft risk evaluation.
EPA is committed to being open and transparent as the agency follows the process required by the law for evaluating unreasonable risks from chemicals. EPA will continue to keep the public updated as the agency moves through the risk management process for chrysotile asbestos and in development of Part 2 of the Risk Evaluation for Asbestos. Following the comprehensive risk evaluation process required by TSCA ensures that the public has confidence in EPA’s final conclusions about whether a chemical substance poses any unreasonable risks to health or the environment under the conditions of use. This then allows the public to have confidence in the risk management actions taken to ensure the safety of chemicals on the market.
There will be additional opportunities for public participation. Just like the risk evaluation process, there will be opportunities for public comment as EPA works to propose and finalize risk management actions for asbestos. You can stay informed by signing up for our email alerts or checking the public docket at www.regulations.gov.
Final Risk Evaluation and Supporting Files
The final risk evaluation for asbestos, part 1: Chrysotile Asbestos, non-technical summary, response to comments, and other supporting documents are below.
- Risk Evaluation for Asbestos Part I: Chrysotile Asbestos (pdf)
- Nontechnical Summary of the Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos (pdf)
- Summary of External Peer Review and Public Comments for Asbestos and Disposition for Asbestos Part 1: Chrysotile Asbestos (pdf)
- Final Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos Systematic Review Supplemental File: Data Quality Evaluation of Physical-Chemical Properties Studies (pdf)
- Final Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos Systematic Review Supplemental File: Data Quality Extraction of Environmental Fate and Transport Studies (pdf)
- Final Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos Systematic Review Supplemental File: Data Quality Evaluation of Environmental Releases and Occupational Exposure Data (pdf)
- Final Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos Systematic Review Supplemental File: Data Quality Evaluation of Environmental Releases and Occupational Exposure Common Sources (pdf)
- Final Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos Systematic Review Supplemental File: Data Quality Evaluation for Consumer Exposure (pdf)
- Final Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos Systematic Review Supplemental File: Data Extraction for Consumer Exposure (pdf)
- Final Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos Systematic Review Supplemental File: Data Quality Evaluation of Ecological Hazard Studies (pdf)
- Final Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos Systematic Review Supplemental File: Data Quality Evaluation of Human Health Hazard Studies: Mesothelioma and Lung Cancer Studies (pdf)
- Final Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos Systematic Review Supplemental File: Data Quality Evaluation of Human Health Hazard Studies: Mesothelioma and Lung Cancer Studies (pdf)
- Final Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos Summary of External Peer Review and Public Comments and Disposition Supplemental File for Epidemiologic Studies of Automotive Mechanics (pdf)
- Final Risk Evaluation for Asbestos Part 1: Chrysotile Asbestos Systematic Review Supplemental File: Data Quality Evaluation for Epidemiological Studies of Ovarian and Laryngeal Cancers (pdf)